Skip to content

Clinical trials

Terminated Hepatic Encephalopathy trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatic Encephalopathy Status: Terminated Country / region: United States Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20122
20133
20171
20212
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
NYU Langone Health2
Amgen1
Axcella Health, Inc1
Bausch Health Americas, Inc.1
Genfit1
Ochsner Health System1
Stanford University1
Tampa General Hospital1
University of Arkansas1
University of Miami1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatic Encephalopathy11
Fibrosis5
Liver Cirrhosis3
Brain Diseases2
Hypertension, Portal2
Acute-On-Chronic Liver Failure1
Ascites1
End Stage Liver Disease1
Fatigue1
Hepatic Insufficiency1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.